Mainboard-listed Thomson Medical Centre, one of the leading private healthcare providers for women and children, posted a 27.8% surge in net profit after tax (NPAT) to $16.3 million for the financial year ended 31 August 2010 (FY2010) on the back of a 21.2% growth in revenue to $81.7 million.
Revenue from Hospital Operations and Ancillary Services segment increased 11.2% from $51.9 million in FY2009 to $57.7 million in FY2010, representing 70.6% of the group’s total revenue.
The strong growth in this business segment was due to a 4.2% rise in number of patient referrals, increase in deliveries of 4.1% from 8,907 babies in FY 2009 to 9,268 babies in FY2010 and strong growth in diagnostic imaging services, Parentcraft services and other ancillary services.
Revenue from Specialised and Other Services surged 54.7% to $24.0 million in FY2010 from $15.5 million in FY2009. This is attributable to strong debut by our 8-month old Thomson Paediatric Centre (TPC), full year contribution from Thomson Women Cancer Centre (TWCC) and continued growth in patient load and revenue from our network of clinics under Thomson Women Clinics (TWC)
The net profit grew by 28.3% to $16.3 million mainly due to the growth in revenue, better gross margin and prudent management of administrative and other operating expenses. The increase in these expenses is attributable mainly to higher staff count and depreciation charges in relation to the renovation of the wards in FY 2009.
The group’s financial position remains strong with a fixed deposit and cash and bank balance of $30.5 million as at 31 August 2010, up from $20.6 million as at 31 August 2009. Bank borrowings decreased to $1.4 million as at 31 August 2010 from $2.7 million as at 31 August 2009 with gearing ratio of less than 1%. The group maintained its net cash position and generated $22.2 million of operating cash flow in FY2010, up 15.7% from $19.1 million in FY 2009. Total equity rose to $142.1 million from $111.3 million. Net asset value per share rose 27.2% from 38.12 cents per share to 48.48 cents per share.
Directors are recommending a one- tier tax-exempt final dividend of 2.0 cents per shares representing a payout ratio of 57.8%.